Stock Scorecard
Stock Summary for Johnson & Johnson (JNJ) - $241.50 as of 4/10/2026 6:21:39 PM EST
Total Score
10 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for JNJ
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JNJ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JNJ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JNJ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JNJ (56 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for JNJ
Financial Details for JNJ
Company Overview |
|
|---|---|
| Ticker | JNJ |
| Company Name | Johnson & Johnson |
| Country | N/A |
| Description | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 241.50 |
| Price 4 Years Ago | 160.45 |
| Last Day Price Updated | 4/10/2026 6:21:39 PM EST |
| Last Day Volume | 7,323,850 |
| Average Daily Volume | 7,811,491 |
| 52-Week High | 251.71 |
| 52-Week Low | 141.20 |
| Last Price to 52 Week Low | 71.03% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 30.40 |
| Sector PE | 61.45 |
| 5-Year Average PE | 12.19 |
| Free Cash Flow Ratio | 29.52 |
| Industry Free Cash Flow Ratio | 50.39 |
| Sector Free Cash Flow Ratio | 26.49 |
| Current Ratio Most Recent Quarter | 1.03 |
| Total Cash Per Share | 8.18 |
| Book Value Per Share Most Recent Quarter | 33.87 |
| Price to Book Ratio | 7.18 |
| Industry Price to Book Ratio | 11.83 |
| Sector Price to Book Ratio | 16.97 |
| Price to Sales Ratio Twelve Trailing Months | 6.10 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.07 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.01 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 2,408,613,000 |
| Market Capitalization | 581,680,039,500 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/24/2026 |
| Previous Dividend Amount | 1.3000 |
| Current Dividend Amount | 1.3000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 5.20 |
| Trailing Annual Dividend Yield | 2.18% |
| Forward Annual Dividend Rate | 5.20 |
| Forward Annual Dividend Yield | 2.18% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 2.50% |
| 5-Year Average Dividend Yield | 3.00% |
| 1-Year Dividend Growth Rate Percentage | 1.17% |
| 3-Year Dividend Growth Rate Percentage | 0.58% |
| 5-Year Dividend Growth Rate Percentage | 3.97% |
| All-Time Dividend Growth Rate Percentage | 12.87% |
| Dividend Payout Ratio | 47.10% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 48.60% |
| Annual Earnings Growth | 90.56% |
| Reported EPS 12 Trailing Months | 11.04 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 12.57 |
| Net Income Twelve Trailing Months | 26,804,000,000 |
| Net Income Past Year | 26,804,000,000 |
| Net Income Prior Year | 14,066,000,000 |
| Quarterly Revenue Growth YOY | 9.10% |
| 5-Year Revenue Growth | 2.67% |
| Operating Margin Twelve Trailing Months | 24.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 19,709,000,000 |
| Total Cash Past Year | 19,709,000,000 |
| Total Cash Prior Year | 24,105,000,000 |
| Net Cash Position Most Recent Quarter | -19,729,000,000 |
| Net Cash Position Past Year | -19,729,000,000 |
| Long Term Debt Past Year | 39,438,000,000 |
| Long Term Debt Prior Year | 30,651,000,000 |
| Total Debt Most Recent Quarter | 39,438,000,000 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.67 |
| Total Stockholder Equity Past Year | 81,544,000,000 |
| Total Stockholder Equity Prior Year | 71,490,000,000 |
| Total Stockholder Equity Most Recent Quarter | 81,544,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 19,698,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 8.18 |
| Free Cash Flow Past Year | 19,698,000,000 |
| Free Cash Flow Prior Year | 19,842,000,000 |
Options |
|
| Put/Call Ratio | 0.81 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.33 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 4/16/2026 2:25:55 AM EST |